XENTINEL Trademark

Trademark Overview

On Tuesday, April 5, 2016, a trademark application was filed for XENTINEL with the United States Patent and Trademark Office. The USPTO has given the XENTINEL trademark a serial number of 86965374. The federal status of this trademark filing is REGISTERED as of Tuesday, July 7, 2020. This trademark is owned by Cipherome, Inc.. The XENTINEL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research services, namely, providing genome information that provides patients with personalized drug reaction risk information; [ medical computer software diagnostics development platform featuring temporary use of online non-downloadable software and featuring temporary use of online non-downloadable diagnostics software tools for identification and diagnosis of individuals at risk for adverse drug reactions; ] temporary use of online non-downloadable software for genome and whole exome-based drug discovery featuring drug repositioning and drug-gene interactions [ ; providing temporary use of online non-downloadable software that facilitates development of molecular diagnostic tools for personalized drug choice for patients and healthcare providers; testing, analysis and evaluation of genetic causes of adverse drug reactions in patients ]
xentinel

General Information

Serial Number86965374
Word MarkXENTINEL
Filing DateTuesday, April 5, 2016
Status700 - REGISTERED
Status DateTuesday, July 7, 2020
Registration Number6096625
Registration DateTuesday, July 7, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements

Amendment to a Registration/Renewal CertificateThe class 42 goods are amended to appear as follows: Medical and scientific research services, namely, providing genome information that provides patients with personalized drug reaction risk information; temporary use of online non-downloadable software for genome and whole exome-based drug discovery featuring drug repositioning and drug-gene interactions
Goods and ServicesMedical and scientific research services, namely, providing genome information that provides patients with personalized drug reaction risk information; [ medical computer software diagnostics development platform featuring temporary use of online non-downloadable software and featuring temporary use of online non-downloadable diagnostics software tools for identification and diagnosis of individuals at risk for adverse drug reactions; ] temporary use of online non-downloadable software for genome and whole exome-based drug discovery featuring drug repositioning and drug-gene interactions [ ; providing temporary use of online non-downloadable software that facilitates development of molecular diagnostic tools for personalized drug choice for patients and healthcare providers; testing, analysis and evaluation of genetic causes of adverse drug reactions in patients ]

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 11, 2016
Primary Code042
First Use Anywhere DateTuesday, March 31, 2020
First Use In Commerce DateTuesday, March 31, 2020

Trademark Owner History

Party NameCipherome, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95134
Party NameCipherome, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95134
Party NameCipherome, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCupertino, CA 95014

Trademark Events

Event DateEvent Description
Friday, April 8, 2016NEW APPLICATION ENTERED
Monday, April 11, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 19, 2016ASSIGNED TO EXAMINER
Wednesday, July 20, 2016NON-FINAL ACTION WRITTEN
Wednesday, July 20, 2016NON-FINAL ACTION E-MAILED
Wednesday, July 20, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 23, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 7, 2017ASSIGNED TO LIE
Wednesday, February 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 21, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, November 21, 2017SOU EXTENSION 1 FILED
Tuesday, November 21, 2017SOU EXTENSION 1 GRANTED
Thursday, November 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 11, 2018SOU TEAS EXTENSION RECEIVED
Friday, May 11, 2018SOU EXTENSION 2 FILED
Friday, May 11, 2018SOU EXTENSION 2 GRANTED
Tuesday, May 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 19, 2018SOU TEAS EXTENSION RECEIVED
Friday, October 19, 2018SOU EXTENSION 3 FILED
Friday, October 19, 2018SOU EXTENSION 3 GRANTED
Tuesday, October 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 9, 2018ASSIGNED TO EXAMINER
Wednesday, May 22, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, May 22, 2019SOU EXTENSION 4 FILED
Wednesday, May 22, 2019SOU EXTENSION 4 GRANTED
Friday, May 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2019SOU TEAS EXTENSION RECEIVED
Monday, November 18, 2019SOU EXTENSION 5 FILED
Thursday, November 21, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 21, 2019SOU EXTENSION 5 GRANTED
Friday, November 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 22, 2020TEAS STATEMENT OF USE RECEIVED
Friday, May 22, 2020USE AMENDMENT FILED
Wednesday, May 27, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 2, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 3, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 7, 2020REGISTERED-PRINCIPAL REGISTER
Friday, November 10, 2023TEAS SECTION 7 REQUEST RECEIVED
Tuesday, June 18, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 27, 2024POST REGISTRATION ACTION MAILED - SEC. 7
Friday, August 16, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, August 21, 2024AMENDMENT UNDER SECTION 7 - PROCESSED
Thursday, August 22, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Related Keywords

xentinel drug software online downloadable temporary patients featuring reactions adverse diagnostics